Search Results - "Karimova, A. R."

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Metformin and malignant neoplasms: a possible mechanism of antitumor action and prospects for use in practice by Kuznetsov, K. O., Safina, E. R., Gaimakova, D. V., Frolova, Ya. S., Oganesyan, I. Yu, Sadertdinova, A. G., Nazmieva, K. A., Islamgulov, A. H., Karimova, A. R., Galimova, A. M., Rizvanova, E. V.

    Published in Problemy ėndokrinologii (14-07-2022)
    “…Metformin is a first-line antidiabetic drug for the treatment of type 2 diabetes mellitus (DM2); its molecular target is AMP-activated protein kinase (AMPK),…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5

    Metformin and malignant neoplasms: a possible mechanism of antitumor action and prospects for use in practice by Kuznetsov, K O, Safina, E R, Gaimakova, D V, Frolova, Ya S, Oganesyan, I Yu, Sadertdinova, A G, Nazmieva, K A, Islamgulov, A H, Karimova, A R, Galimova, A M, Rizvanova, E V

    Published in Problemy endokrinologii (14-07-2022)
    “…Metformin is a first-line antidiabetic drug for the treatment of type 2 diabetes mellitus (DM2); its molecular target is AMP-activated protein kinase (AMPK),…”
    Get more information
    Journal Article
  6. 6
  7. 7
  8. 8